Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Norepinephrine for Kasai Operation
NCT05521152Phase 3Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Aug 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of norepinephrine in hypotension, sponsored by Kasr Al Ainy Hospital. Started Aug 2022; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05521152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05521152.